Clinical Trial Update: Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating allopurinol for neurocognitive outcomes after hypoxic-ischemic brain injury in newborns; status of the trial is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy
• Newborn Infant Diseases

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Encephalopathy, Hypoxic-Ischemic, Infant, Newborn, Diseases | Phase 3 | Status: UNKNOWN